But, in the interim, patients deserve, at the very least, accurate information so they, and their healthcare provider, can make informed decisions about their health
Impairment of short-chain fatty acid (SCFA) and l-isoleucine biosynthesis in gut microbiome persists beyond 30 days after recovery from COVID-19, which could contribute to persistent leaky gut and dysbiosis in PASC patients 237,238
These shifts can be subtle at first, but theyre signs that tirzepatide is already activating GIP and GLP-1 receptors in your brain and gut
Most people regain some weight within a year after stopping, though some weight loss benefits may persist
This approach will enhance the interpretation of these associations and allow for an examination of their developmental trajectories